Epstein Secrets

e other EFTA00135850 half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

hey operate in." NYTimes Profiles Scandal-Plagued Executive For Chinese Vaccine Manufacturer. In a 2,900-word profile of Du Weimin, the Chairman of Shenzhen Kangtai Biological Products, the New York Times (12/7, Wee, Hernandez, 18.61M) highlights a 2016 bribery scandal linked to Du, whose company "will be the exclusive manufacture

and hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people n

" EFTA00137475 NYTimes Profiles Scandal-Plagued Executive For Chinese Vaccine Manufacturer. In a 2,900-word profile of Du Weimin, the Chairman of Shenzhen Kangtai Biological Products, the New York Times <https://www.nytimes.com/2020/12/07/business/china-vaccine-astrazeneca.html> (12/7, Wee, Hernandez, 18.6IM) highlights a 2016 b

nd hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

" NYTimes Profiles Scandal-Plagued Executive For Chinese Vaccine Manufacturer. EFTA00148157 In a 2,900-word profile of Du Weimin, the Chairman of Shenzhen Kangtai Biological Products, the New York Times (12/7, Wee, Hernandez, 18.61M) highlights a 2016 bribery scandal linked to Du, whose company "will be the exclusive manufacture